Please ensure Javascript is enabled for purposes of website accessibility
Home / Therapeutic Targets & Antibodies / DR5/CD262/TRAIL-R2
Product Menu
Product Menu Close
DR5/CD262/TRAIL-R2

 

CD262 which is also known as, TNF-related apoptosis-inducing ligand receptor 2 (TRAIL Receptor 2, TRAIL-R2), Death receptor 5 (DR5), TRICK2, or KILLER. CD262 is a type I transmembrane protein that is encoded by TNFRSF10B (Tumor necrosis factor receptor superfamily, member 10b). DR5 forms a homotrimeric receptor complex that can bind homotrimeric TRAIL (CD253/APO-2 Ligand) and transduce apoptotic signals intracellularly through its cytoplasmic death domain (DD). DR5 is differentially expressed on cells from a wide variety of normal tissues and tumors. DR5 expression is upregulated by Interferon-α (IFN-α). Death receptor 5 is activated by fucosylation in colon cancer cells The remarkable pro-apoptotic properties of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) have led to considerable interest in this protein as a potential anticancer therapeutic.

1 product selected Compare
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only